首页 > 最新文献

Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery最新文献

英文 中文
TREATMENT OF GASTRIC CANCER ACCORDING TO THE COMPLEXITY OF THE HOSPITAL ONCOLOGY UNIT: ANALYSIS OF 33,774 PATIENTS OVER TWO DECADES. 根据医院肿瘤单位复杂程度治疗胃癌:二十年来33,774例患者分析
Pub Date : 2024-12-16 eCollection Date: 2024-01-01 DOI: 10.1590/0102-6720202400052e1846
Marcus Fernando Kodama Pertille Ramos, Marina Alessandra Pereira, Carolina Terra de Moraes Luizaga, Valeria Lombardo, Valter Bezerra Leite, Stela Verzinhasse Peres, Rodrigo Nascimento Pinheiro, Ulysses Ribeiro Junior

Background: The hospitals' volume, specialization, availability of all oncological services, and experience in performing complex surgeries have a favorable impact on gastric cancer (GC) treatment.

Aims: The aim of this study was to compare the results of GC treatment according to the type of oncological hospital in the State of São Paulo.

Methods: Patients diagnosed with GC between 2000 and 2022 in qualified hospitals for cancer treatment were evaluated by data extracted from the hospital cancer registry. Patients were assessed according to the type of hospital for cancer treatment: Oncology High Complexity Assistance Unit (UNACON) and Oncology High Complexity Care Center (CACON), which has greater complexity.

Results: Among the 33,774 patients, 23,387 (69.2%) were treated at CACONs and 10,387 (30.8%) in UNACONs. CACON patients were younger, had a higher level of education, and had a more advanced cTNM stage compared to UNACON (all p<0.001, p<0.05). The time from diagnosis to treatment was over 60 days in 49.8% of CACON's patients and 39.4% of UNACON's (p<0.001, p<0.05). Surgical treatment was performed in 18,314 (54.2%) patients. The frequency pN0 (40.3 vs 32.4%) and pTNM stage I (23 vs 19.5%) were higher in CACON. There was no difference in overall survival (OS) between all adenocarcinoma cases treated at CACON and UNACON (9.3 vs 10.3 months, p=0.462, p>0.05). However, considering only patients who underwent curative surgery, the OS of patients treated at CACON was better (24.4 vs 18 months, p<0.001).

Conclusions: Patients with GC who underwent gastrectomy at CACONs had better survival outcomes, suggesting that the centralization of complex cancer surgery may be beneficial.

背景:医院的规模、专业、所有肿瘤服务的可及性以及复杂手术的经验对胃癌(GC)的治疗有有利的影响。目的:本研究的目的是比较圣保罗州肿瘤医院类型的GC治疗结果。方法:对2000年至2022年在有资质的肿瘤治疗医院诊断为胃癌的患者进行评估,数据提取自医院肿瘤登记处。根据肿瘤治疗医院的类型对患者进行评估:肿瘤高复杂性援助中心(UNACON)和肿瘤高复杂性护理中心(CACON),后者的复杂性更大。结果:33774例患者中,23387例(69.2%)在CACONs接受治疗,10387例(30.8%)在UNACONs接受治疗。与UNACON相比,CACON患者年龄更小,受教育程度更高,cTNM分期更晚(均p0.05)。然而,仅考虑接受根治性手术的患者,在CACON治疗的胃癌患者的OS更好(24.4 vs 18个月)。结论:在CACON接受胃切除术的胃癌患者有更好的生存结果,提示复杂癌症手术的集中化可能是有益的。
{"title":"TREATMENT OF GASTRIC CANCER ACCORDING TO THE COMPLEXITY OF THE HOSPITAL ONCOLOGY UNIT: ANALYSIS OF 33,774 PATIENTS OVER TWO DECADES.","authors":"Marcus Fernando Kodama Pertille Ramos, Marina Alessandra Pereira, Carolina Terra de Moraes Luizaga, Valeria Lombardo, Valter Bezerra Leite, Stela Verzinhasse Peres, Rodrigo Nascimento Pinheiro, Ulysses Ribeiro Junior","doi":"10.1590/0102-6720202400052e1846","DOIUrl":"10.1590/0102-6720202400052e1846","url":null,"abstract":"<p><strong>Background: </strong>The hospitals' volume, specialization, availability of all oncological services, and experience in performing complex surgeries have a favorable impact on gastric cancer (GC) treatment.</p><p><strong>Aims: </strong>The aim of this study was to compare the results of GC treatment according to the type of oncological hospital in the State of São Paulo.</p><p><strong>Methods: </strong>Patients diagnosed with GC between 2000 and 2022 in qualified hospitals for cancer treatment were evaluated by data extracted from the hospital cancer registry. Patients were assessed according to the type of hospital for cancer treatment: Oncology High Complexity Assistance Unit (UNACON) and Oncology High Complexity Care Center (CACON), which has greater complexity.</p><p><strong>Results: </strong>Among the 33,774 patients, 23,387 (69.2%) were treated at CACONs and 10,387 (30.8%) in UNACONs. CACON patients were younger, had a higher level of education, and had a more advanced cTNM stage compared to UNACON (all p<0.001, p<0.05). The time from diagnosis to treatment was over 60 days in 49.8% of CACON's patients and 39.4% of UNACON's (p<0.001, p<0.05). Surgical treatment was performed in 18,314 (54.2%) patients. The frequency pN0 (40.3 vs 32.4%) and pTNM stage I (23 vs 19.5%) were higher in CACON. There was no difference in overall survival (OS) between all adenocarcinoma cases treated at CACON and UNACON (9.3 vs 10.3 months, p=0.462, p>0.05). However, considering only patients who underwent curative surgery, the OS of patients treated at CACON was better (24.4 vs 18 months, p<0.001).</p><p><strong>Conclusions: </strong>Patients with GC who underwent gastrectomy at CACONs had better survival outcomes, suggesting that the centralization of complex cancer surgery may be beneficial.</p>","PeriodicalId":72298,"journal":{"name":"Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery","volume":"37 ","pages":"e1846"},"PeriodicalIF":0.0,"publicationDate":"2024-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11655069/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142857156","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
USE OF DECELLULARIZED HUMAN AMNIOTIC MEMBRANE IN INTESTINAL ANASTOMOSES: A STUDY IN RATS TREATED WITH 5-FLUOROURACIL. 脱细胞人羊膜在肠吻合术中的应用:5-氟尿嘧啶处理大鼠的研究。
Pub Date : 2024-12-16 eCollection Date: 2024-01-01 DOI: 10.1590/0102-6720202400049e1843
Daniel Dantas Ferrarin, Osvaldo Malafaia, Nicolau Gregori Czeczko, Luiz Fernando Kubrusly, Marcos Fabiano Sigwalt, Eros Luiz de Sousa, João Carlos Domingues Repka, Pedro Henrique Lambach Caron

Background: Nowdays, more relevant applications of perinatal derivatives, such as amniotic membrane (AM), are emerging in our environment as a source of biomaterials for use in different healing processes. The study of anastomosis healing associated with antimetabolic drugs such as 5-fluorouracil (5-FU) is a potential target of AM.

Aims: To evaluate the healing effects of AM in rats treated with 5-FU at a dose of 20 mg/kg on the seventh day of postoperative evolution, regarding the parameters percentage of type I collagen (mature), cell viability, microvascular density and formation of granulation tissue.

Methods: Thirty-two Wistar rats were used, submitted to colotomy and colorraphy, separated into four groups of eight, which received different treatments daily, intraperitoneally, until the day of sacrifice: saline solution (C), 20 mg/kg 5-FU, 20 mg/kg 5-FU and AM.

Results: Treatment with 20 mg/kg of 5-FU, on the seventh postoperative day, induced adverse effects on the anastomotic healing process, evidenced by a decrease in the percentage of type I (mature) collagen, cell viability, microvascular density, fibrin-leukocyte scab formation and angiofibroblast proliferation; the use of AM under these conditions induced an improvement in the percentage of type I (mature) collagen.

Conclusions: Treatment with 20 mg/kg of 5-FU on the seventh postoperative day induced adverse effects on the anastomotic healing process, and the use of AM under these conditions induced an improvement in the percentage of type I (mature) collagen.

背景:如今,围产期衍生物的更多相关应用,如羊膜(AM),正在出现在我们的环境中,作为生物材料的来源,用于不同的愈合过程。吻合口愈合与抗代谢药物如5-氟尿嘧啶(5-FU)相关的研究是AM的潜在靶点。目的:评价AM对术后第7天5-FU剂量20 mg/kg大鼠的愈合作用,包括I型胶原(成熟)百分比、细胞活力、微血管密度和肉芽组织形成等参数。方法:选用Wistar大鼠32只,行结肠切开和染色,分为4组,每组8只,每天分别腹腔注射生理盐水(C)、5-FU 20 mg/kg、5-FU 20 mg/kg和AM,直至祭祀当日。结果:术后第7天给予5-FU 20 mg/kg,对吻合口愈合过程产生不良影响,表现为ⅰ型(成熟)胶原百分比、细胞活力、微血管密度、纤维蛋白-白细胞结痂形成和血管成纤维细胞增殖降低;在这些条件下使用AM诱导I型(成熟)胶原百分比的改善。结论:术后第7天用20 mg/kg 5-FU治疗会对吻合口愈合过程产生不良影响,在此条件下使用AM可改善I型(成熟)胶原的百分比。
{"title":"USE OF DECELLULARIZED HUMAN AMNIOTIC MEMBRANE IN INTESTINAL ANASTOMOSES: A STUDY IN RATS TREATED WITH 5-FLUOROURACIL.","authors":"Daniel Dantas Ferrarin, Osvaldo Malafaia, Nicolau Gregori Czeczko, Luiz Fernando Kubrusly, Marcos Fabiano Sigwalt, Eros Luiz de Sousa, João Carlos Domingues Repka, Pedro Henrique Lambach Caron","doi":"10.1590/0102-6720202400049e1843","DOIUrl":"10.1590/0102-6720202400049e1843","url":null,"abstract":"<p><strong>Background: </strong>Nowdays, more relevant applications of perinatal derivatives, such as amniotic membrane (AM), are emerging in our environment as a source of biomaterials for use in different healing processes. The study of anastomosis healing associated with antimetabolic drugs such as 5-fluorouracil (5-FU) is a potential target of AM.</p><p><strong>Aims: </strong>To evaluate the healing effects of AM in rats treated with 5-FU at a dose of 20 mg/kg on the seventh day of postoperative evolution, regarding the parameters percentage of type I collagen (mature), cell viability, microvascular density and formation of granulation tissue.</p><p><strong>Methods: </strong>Thirty-two Wistar rats were used, submitted to colotomy and colorraphy, separated into four groups of eight, which received different treatments daily, intraperitoneally, until the day of sacrifice: saline solution (C), 20 mg/kg 5-FU, 20 mg/kg 5-FU and AM.</p><p><strong>Results: </strong>Treatment with 20 mg/kg of 5-FU, on the seventh postoperative day, induced adverse effects on the anastomotic healing process, evidenced by a decrease in the percentage of type I (mature) collagen, cell viability, microvascular density, fibrin-leukocyte scab formation and angiofibroblast proliferation; the use of AM under these conditions induced an improvement in the percentage of type I (mature) collagen.</p><p><strong>Conclusions: </strong>Treatment with 20 mg/kg of 5-FU on the seventh postoperative day induced adverse effects on the anastomotic healing process, and the use of AM under these conditions induced an improvement in the percentage of type I (mature) collagen.</p>","PeriodicalId":72298,"journal":{"name":"Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery","volume":"37 ","pages":"e1843"},"PeriodicalIF":0.0,"publicationDate":"2024-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11655074/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142857168","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HEPATECTOMIES: INDICATIONS AND RESULTS FROM A REFERENCE HOSPITAL IN THE BRAZILIAN AMAZON. 肝切除术:指征和结果从参考医院在巴西亚马逊。
Pub Date : 2024-12-16 eCollection Date: 2024-01-01 DOI: 10.1590/0102-6720202400051e1845
Fernanda Oliveira Barreto Garcia, Rafael José Romero Garcia, Mariana Pereira Maurity, Erica Samara Monteiro Nascimento

Background: Hepatectomy is historically associated with higher morbidity and mortality, related to intraoperative blood loss and biliary fistulas. Technological advances and improvements in surgical and anesthetic techniques have led to greater safety in performing these surgeries.

Aims: The aim of this study was to analyze morbidity and mortality in patients undergoing hepatectomy.

Methods: Retrospective cohort study of patients undergoing liver resections. The type of hepatectomy, indications, need for intraoperative blood transfusion, hospital stay, complications, and postoperative mortality were analyzed.

Results: A total of 48 hepatectomies were performed during the studied period, the most common being 26 (54.16%) major hepatectomies, distributed among 13 (50%) left hepatectomies, 11 (42.30%) right hepatectomies, and 2 (7.70%) others. In total, 24 (45.84%) minor hepatectomies were performed, 11 (50%) mono segmentectomies, and 5 (22.72%) left lateral hepatectomies. The main indications for resection in benign diseases were 6 (12.50%) neotropical hepatic hydatidosis, five (10.41%) intrahepatic lithiasis, and in primary malignancies, 9 (18.75%) hepatocarcinomas. There was no need for an intraoperative blood transfusion. Hospital stays after surgery ranged from 2 to 40 days (average=7 days), and 41 (85.42%) patients went to the ICU in the first 72 h after surgery. In total, 9 (18.75%) patients developed postoperative complications. Overall mortality was 2.08%.

Conclusions: Hepatocellular carcinoma and neotropical hydatidosis were the main diseases with surgical indication, and major hepatectomies were the most performed procedures. Morbidity and mortality were in line with results from major global centers.

背景:肝切除术历来具有较高的发病率和死亡率,与术中失血和胆道瘘有关。外科手术和麻醉技术的进步和改进使这些手术的安全性更高。目的:本研究的目的是分析肝切除术患者的发病率和死亡率。方法:对肝切除术患者进行回顾性队列研究。分析肝切除术类型、适应证、术中输血需求、住院时间、并发症和术后死亡率。结果:研究期间共行肝切除术48例,最常见的是26例(54.16%)大肝切除术,其中左肝切除术13例(50%),右肝切除术11例(42.30%),其他2例(7.70%)。共行小肝切除术24例(45.84%),单肝切除术11例(50%),左侧肝切除术5例(22.72%)。良性疾病的主要切除指征为新热带肝包虫病6例(12.50%),肝内结石5例(10.41%),原发性恶性肿瘤9例(18.75%)。术中不需要输血。术后住院时间2 ~ 40天(平均7天),术后前72 h有41例(85.42%)入住ICU。9例(18.75%)患者出现术后并发症。总死亡率为2.08%。结论:肝细胞癌和新热带包虫病是手术指征的主要疾病,主要手术方式为肝切除术。发病率和死亡率与全球主要研究中心的结果一致。
{"title":"HEPATECTOMIES: INDICATIONS AND RESULTS FROM A REFERENCE HOSPITAL IN THE BRAZILIAN AMAZON.","authors":"Fernanda Oliveira Barreto Garcia, Rafael José Romero Garcia, Mariana Pereira Maurity, Erica Samara Monteiro Nascimento","doi":"10.1590/0102-6720202400051e1845","DOIUrl":"10.1590/0102-6720202400051e1845","url":null,"abstract":"<p><strong>Background: </strong>Hepatectomy is historically associated with higher morbidity and mortality, related to intraoperative blood loss and biliary fistulas. Technological advances and improvements in surgical and anesthetic techniques have led to greater safety in performing these surgeries.</p><p><strong>Aims: </strong>The aim of this study was to analyze morbidity and mortality in patients undergoing hepatectomy.</p><p><strong>Methods: </strong>Retrospective cohort study of patients undergoing liver resections. The type of hepatectomy, indications, need for intraoperative blood transfusion, hospital stay, complications, and postoperative mortality were analyzed.</p><p><strong>Results: </strong>A total of 48 hepatectomies were performed during the studied period, the most common being 26 (54.16%) major hepatectomies, distributed among 13 (50%) left hepatectomies, 11 (42.30%) right hepatectomies, and 2 (7.70%) others. In total, 24 (45.84%) minor hepatectomies were performed, 11 (50%) mono segmentectomies, and 5 (22.72%) left lateral hepatectomies. The main indications for resection in benign diseases were 6 (12.50%) neotropical hepatic hydatidosis, five (10.41%) intrahepatic lithiasis, and in primary malignancies, 9 (18.75%) hepatocarcinomas. There was no need for an intraoperative blood transfusion. Hospital stays after surgery ranged from 2 to 40 days (average=7 days), and 41 (85.42%) patients went to the ICU in the first 72 h after surgery. In total, 9 (18.75%) patients developed postoperative complications. Overall mortality was 2.08%.</p><p><strong>Conclusions: </strong>Hepatocellular carcinoma and neotropical hydatidosis were the main diseases with surgical indication, and major hepatectomies were the most performed procedures. Morbidity and mortality were in line with results from major global centers.</p>","PeriodicalId":72298,"journal":{"name":"Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery","volume":"37 ","pages":"e1845"},"PeriodicalIF":0.0,"publicationDate":"2024-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11655073/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142857101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
LONG-TERM SURVIVAL AFTER LAPAROSCOPIC TOTAL GASTRECTOMY FOR EARLY AND ADVANCED GASTRIC CANCER. SINGLE CENTER EXPERIENCE IN 100 CASES. 早期和晚期胃癌腹腔镜全胃切除术后的长期生存率。100例单中心体验。
Pub Date : 2024-12-16 eCollection Date: 2024-01-01 DOI: 10.1590/0102-6720202400050e1844
Enrique Norero, Marco Ceroni, Cristian Martinez, Rodrigo Muñoz, Ricardo Mejia, Emilio Morales, Ignacio Obaid, Paulina Gonzalez

Background: Laparoscopic gastrectomy offers advantages in the postoperative period compared to the open approach. Most studies have been performed on distal gastrectomies; however, laparoscopic total gastrectomy (LTG) is not universally accepted. AIM: The aim of this study was to assess the results of LTG, on postoperative morbidity outcomes and long-term survival.

Methods: This is a retrospective cohort study from a prospective database of patients who underwent LTG, from 2005 to 2022, due to early and advanced gastric cancer. A totally laparoscopic technique was utilized, and the Roux-en-Y reconstruction was performed in all cases. Postoperative complications and long-term survival were evaluated.

Results: A total of 100 patients were included (men 57, age 64 years, and body mass index 26). A D2 lymphadenectomy was performed in 68 cases. The postoperative hospitalization period was 8 days (6-62 days). Postoperative complications occurred in 26%, with 7% esophago-jejunal anastomosis leak, 4% abdominal collections, and 2% gastrointestinal bleeding. In 7% of cases, the complication was considered Clavien 3 or greater. Operative mortality was 1%. The pathology findings confirmed advanced gastric cancer in 50 cases. The median lymph node count was 38, and surgery was considered R0 in 99%. The median follow-up was 50 months. Overall 5-year survival was 74%. Survival in T1 cases was 95% at 5 years. For stage I, survival was 95%, and for stages II and III, it was 52% and 43%, at 5 years, respectively.

Conclusions: These results support the feasibility and oncological adequacy of minimally invasive total gastrectomy. Postoperative morbidity has an acceptable rate. Long-term survival was in accordance with the disease stage.

背景:腹腔镜胃切除术与开放入路相比在术后具有优势。大多数研究都是在远端胃切除术中进行的;然而,腹腔镜全胃切除术(LTG)并没有被普遍接受。目的:本研究的目的是评估LTG对术后发病率、预后和长期生存的影响。方法:这是一项回顾性队列研究,来自2005年至2022年因早期和晚期胃癌而接受LTG的前瞻性数据库。采用全腹腔镜技术,所有病例均行Roux-en-Y重建。观察术后并发症及远期生存率。结果:共纳入100例患者(男性57岁,年龄64岁,体重指数26)。68例行D2淋巴结切除术。术后住院8天(6 ~ 62天)。26%发生术后并发症,7%发生食管-空肠吻合口漏,4%发生腹腔积液,2%发生消化道出血。在7%的病例中,并发症被认为是Clavien 3或更高。手术死亡率为1%。病理证实50例为晚期胃癌。中位淋巴结计数为38,99%认为手术为零。中位随访时间为50个月。总体5年生存率为74%。T1例患者5年生存率为95%。I期5年生存率为95%,II期和III期5年生存率分别为52%和43%。结论:支持微创全胃切除术的可行性和肿瘤学上的充分性。术后发病率是可以接受的。长期生存率与疾病分期一致。
{"title":"LONG-TERM SURVIVAL AFTER LAPAROSCOPIC TOTAL GASTRECTOMY FOR EARLY AND ADVANCED GASTRIC CANCER. SINGLE CENTER EXPERIENCE IN 100 CASES.","authors":"Enrique Norero, Marco Ceroni, Cristian Martinez, Rodrigo Muñoz, Ricardo Mejia, Emilio Morales, Ignacio Obaid, Paulina Gonzalez","doi":"10.1590/0102-6720202400050e1844","DOIUrl":"10.1590/0102-6720202400050e1844","url":null,"abstract":"<p><strong>Background: </strong>Laparoscopic gastrectomy offers advantages in the postoperative period compared to the open approach. Most studies have been performed on distal gastrectomies; however, laparoscopic total gastrectomy (LTG) is not universally accepted. AIM: The aim of this study was to assess the results of LTG, on postoperative morbidity outcomes and long-term survival.</p><p><strong>Methods: </strong>This is a retrospective cohort study from a prospective database of patients who underwent LTG, from 2005 to 2022, due to early and advanced gastric cancer. A totally laparoscopic technique was utilized, and the Roux-en-Y reconstruction was performed in all cases. Postoperative complications and long-term survival were evaluated.</p><p><strong>Results: </strong>A total of 100 patients were included (men 57, age 64 years, and body mass index 26). A D2 lymphadenectomy was performed in 68 cases. The postoperative hospitalization period was 8 days (6-62 days). Postoperative complications occurred in 26%, with 7% esophago-jejunal anastomosis leak, 4% abdominal collections, and 2% gastrointestinal bleeding. In 7% of cases, the complication was considered Clavien 3 or greater. Operative mortality was 1%. The pathology findings confirmed advanced gastric cancer in 50 cases. The median lymph node count was 38, and surgery was considered R0 in 99%. The median follow-up was 50 months. Overall 5-year survival was 74%. Survival in T1 cases was 95% at 5 years. For stage I, survival was 95%, and for stages II and III, it was 52% and 43%, at 5 years, respectively.</p><p><strong>Conclusions: </strong>These results support the feasibility and oncological adequacy of minimally invasive total gastrectomy. Postoperative morbidity has an acceptable rate. Long-term survival was in accordance with the disease stage.</p>","PeriodicalId":72298,"journal":{"name":"Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery","volume":"37 ","pages":"e1844"},"PeriodicalIF":0.0,"publicationDate":"2024-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11655072/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142857104","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
EXPECTANT MANAGEMENT OR CHOLECYSTECTOMY IN ASYMPTOMATIC CHOLELITHIASIS. 无症状胆石症的预期治疗或胆囊切除术。
Pub Date : 2024-12-02 eCollection Date: 2024-01-01 DOI: 10.1590/0102-6720202400047e1841
Eduardo Neubarth Trindade, Lucas Dos Santos Difante, Luiz Roberto Rigo Wendt, Manoel Roberto Maciel Trindade
{"title":"EXPECTANT MANAGEMENT OR CHOLECYSTECTOMY IN ASYMPTOMATIC CHOLELITHIASIS.","authors":"Eduardo Neubarth Trindade, Lucas Dos Santos Difante, Luiz Roberto Rigo Wendt, Manoel Roberto Maciel Trindade","doi":"10.1590/0102-6720202400047e1841","DOIUrl":"10.1590/0102-6720202400047e1841","url":null,"abstract":"","PeriodicalId":72298,"journal":{"name":"Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery","volume":"37 ","pages":"e1841"},"PeriodicalIF":0.0,"publicationDate":"2024-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11654456/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142781996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
LIVING DONOR LIVER TRANSPLANT FOR INTRAHEPATIC CHOLANGIOCARCINOMA. AN INITIAL BRAZILIAN EXPERIENCE. 活体供肝移植治疗肝内胆管癌。最初的巴西经历。
Pub Date : 2024-12-02 eCollection Date: 2024-01-01 DOI: 10.1590/0102-6720202400045e1839
Eduardo de Souza Martins Fernandes, Felipe Pedreira Tavares de Mello, Ronaldo de Oliveira Andrade, Camila Liberato Girão, Camila Cesar, Leandro Savattone Pimentel, Henrique Sergio Moraes Coelho, Samanta Teixeira Basto, Munique Siqueira, Anderson Brito, Claudia Cristina Tavares DE Sousa, Tercio Genzini, Orlando Jorge Martins Torres

Background: Intrahepatic cholangiocarcinoma (iCCA) was considered a contraindication for liver transplantation. However, recent studies have shown that highly selected cases of patients with a good response to neoadjuvant therapy may achieve acceptable survival rates when following liver transplantation.

Aims: To present two cases of patients with iCCA, without extrahepatic disease, who underwent living donor liver transplantation after receiving neoadjuvant chemotherapy.

Methods: Two cases of patients with histopathological diagnosis of locally advanced iCCA, ineligible for resection and without evidence of extrahepatic disease, are presented.

Results: These patients underwent at least nine sessions of neoadjuvant chemotherapy, including Gemcitabine and Cisplatin, with or without the addition of immunobiological agents, resulting in a radiological tumor response. They subsequently underwent living donor liver transplantation. The average follow-up time was 15 months, with no clinical or radiological signs of disease.

Conclusions: In well-selected patients without extrahepatic disease, living donor liver transplantation represents a potential therapeutic option for iCCA.

背景:肝内胆管癌(iCCA)被认为是肝移植的禁忌症。然而,最近的研究表明,高度选择的对新辅助治疗反应良好的患者在肝移植后可能达到可接受的生存率。目的:介绍2例无肝外病变的iCCA患者,在接受新辅助化疗后行活体供肝移植。方法:报告2例组织病理学诊断为局部晚期iCCA,不适合切除且无肝外病变证据的患者。结果:这些患者接受了至少9个疗程的新辅助化疗,包括吉西他滨和顺铂,有或没有添加免疫生物学药物,导致放射学肿瘤反应。他们随后接受了活体供体肝移植。平均随访时间为15个月,无临床或放射学症状。结论:在精心挑选的无肝外疾病的患者中,活体供体肝移植是iCCA的潜在治疗选择。
{"title":"LIVING DONOR LIVER TRANSPLANT FOR INTRAHEPATIC CHOLANGIOCARCINOMA. AN INITIAL BRAZILIAN EXPERIENCE.","authors":"Eduardo de Souza Martins Fernandes, Felipe Pedreira Tavares de Mello, Ronaldo de Oliveira Andrade, Camila Liberato Girão, Camila Cesar, Leandro Savattone Pimentel, Henrique Sergio Moraes Coelho, Samanta Teixeira Basto, Munique Siqueira, Anderson Brito, Claudia Cristina Tavares DE Sousa, Tercio Genzini, Orlando Jorge Martins Torres","doi":"10.1590/0102-6720202400045e1839","DOIUrl":"10.1590/0102-6720202400045e1839","url":null,"abstract":"<p><strong>Background: </strong>Intrahepatic cholangiocarcinoma (iCCA) was considered a contraindication for liver transplantation. However, recent studies have shown that highly selected cases of patients with a good response to neoadjuvant therapy may achieve acceptable survival rates when following liver transplantation.</p><p><strong>Aims: </strong>To present two cases of patients with iCCA, without extrahepatic disease, who underwent living donor liver transplantation after receiving neoadjuvant chemotherapy.</p><p><strong>Methods: </strong>Two cases of patients with histopathological diagnosis of locally advanced iCCA, ineligible for resection and without evidence of extrahepatic disease, are presented.</p><p><strong>Results: </strong>These patients underwent at least nine sessions of neoadjuvant chemotherapy, including Gemcitabine and Cisplatin, with or without the addition of immunobiological agents, resulting in a radiological tumor response. They subsequently underwent living donor liver transplantation. The average follow-up time was 15 months, with no clinical or radiological signs of disease.</p><p><strong>Conclusions: </strong>In well-selected patients without extrahepatic disease, living donor liver transplantation represents a potential therapeutic option for iCCA.</p>","PeriodicalId":72298,"journal":{"name":"Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery","volume":"37 ","pages":"e1839"},"PeriodicalIF":0.0,"publicationDate":"2024-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11654463/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142781997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PANCREATODUODENECTOMY AS TREATMENT FOR RECURRENT ACUTE PANCREATITIS DUE TO PANCREAS DIVISUM. 胰十二指肠切除术治疗胰脏分裂所致复发性急性胰腺炎。
Pub Date : 2024-12-02 eCollection Date: 2024-01-01 DOI: 10.1590/0102-6720202400040e1834
Elizeu Bruno Santos Silva, Maiza Conceição da Silva, Maria Clara Santos Araújo, Beatriz Melo Santos Lima Paulino, José Maria Assunção Moraes-Junior, Orlando Jorge Martins Torres

Background: Pancreas divisum is an anatomical abnormality where the junction of the main and accessory pancreatic duct fails to occur and the smaller-caliber duct acts as dominant, resulting in overload during the drainage of the organ's secretion through the minor duodenal papilla.

Aims: To report a case of recurrent acute pancreatitis due to symptomatic pancreas divisum who underwent pancreatoduodenectomy.

Case report: A 21-year-old male patient presented with intermittent painful crises, located in the upper abdomen, with radiation to the back, associated with nausea and vomiting, for the past three years. Magnetic resonance imaging and endoscopic retrograde cholangiopancreatography revealed pancreas divisum, subsequently confirmed by endoscopic ultrasound. An attempt was made through endoscopic intervention but failed to catheterize the minor papilla; therefore, a pancreaticoduodenectomy was indicated. The organ was identified as hard and atrophied, with moderate peripancreatic inflammation. The histopathological findings also identified a focal well-differentiated G1-type neuroendocrine tumor measuring 0.4 cm.

Conclusions: In patients with pancreas divisum, rare cases may progress to recurrent acute pancreatitis. Pancreaticoduodenectomy is an option in symptomatic patients who had no success with endoscopic treatment.

背景:胰腺分裂是一种解剖异常,由于主胰管和副胰管无法连接,小口径胰管占主导地位,导致器官分泌物通过十二指肠小乳头排出时过载。目的:报告一例因症状性胰腺分裂而复发性急性胰腺炎行胰十二指肠切除术的病例。病例报告:一名21岁的男性患者,在过去的三年里,出现间歇性的疼痛危机,位于上腹部,放射到背部,伴有恶心和呕吐。磁共振及内窥镜逆行胰胆管造影显示胰腺分裂,随后经内窥镜超声证实。内镜下介入治疗,小乳头插管失败;因此,建议行胰十二指肠切除术。该器官坚硬、萎缩,伴有中度胰腺周围炎症。组织病理学结果还发现局灶性高分化g1型神经内分泌肿瘤,直径0.4 cm。结论:在胰腺分裂患者中,极少数可能发展为复发性急性胰腺炎。胰十二指肠切除术是内镜治疗无效的有症状患者的一种选择。
{"title":"PANCREATODUODENECTOMY AS TREATMENT FOR RECURRENT ACUTE PANCREATITIS DUE TO PANCREAS DIVISUM.","authors":"Elizeu Bruno Santos Silva, Maiza Conceição da Silva, Maria Clara Santos Araújo, Beatriz Melo Santos Lima Paulino, José Maria Assunção Moraes-Junior, Orlando Jorge Martins Torres","doi":"10.1590/0102-6720202400040e1834","DOIUrl":"10.1590/0102-6720202400040e1834","url":null,"abstract":"<p><strong>Background: </strong>Pancreas divisum is an anatomical abnormality where the junction of the main and accessory pancreatic duct fails to occur and the smaller-caliber duct acts as dominant, resulting in overload during the drainage of the organ's secretion through the minor duodenal papilla.</p><p><strong>Aims: </strong>To report a case of recurrent acute pancreatitis due to symptomatic pancreas divisum who underwent pancreatoduodenectomy.</p><p><strong>Case report: </strong>A 21-year-old male patient presented with intermittent painful crises, located in the upper abdomen, with radiation to the back, associated with nausea and vomiting, for the past three years. Magnetic resonance imaging and endoscopic retrograde cholangiopancreatography revealed pancreas divisum, subsequently confirmed by endoscopic ultrasound. An attempt was made through endoscopic intervention but failed to catheterize the minor papilla; therefore, a pancreaticoduodenectomy was indicated. The organ was identified as hard and atrophied, with moderate peripancreatic inflammation. The histopathological findings also identified a focal well-differentiated G1-type neuroendocrine tumor measuring 0.4 cm.</p><p><strong>Conclusions: </strong>In patients with pancreas divisum, rare cases may progress to recurrent acute pancreatitis. Pancreaticoduodenectomy is an option in symptomatic patients who had no success with endoscopic treatment.</p>","PeriodicalId":72298,"journal":{"name":"Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery","volume":"37 ","pages":"e1834"},"PeriodicalIF":0.0,"publicationDate":"2024-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11654164/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142781998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ASSOCIATION BETWEEN SURGICAL VOLUME AND MORTALITY FROM COLON CANCER IN COLOMBIA: A NATIONAL COHORT. 哥伦比亚结肠癌手术量与死亡率的关系:一项国家队列研究。
Pub Date : 2024-12-02 eCollection Date: 2024-01-01 DOI: 10.1590/0102-6720202400041e1835
María Fernanda Castro-Cuarán, Edgar German Junca, Diego Felipe Gonzalez-Patiño, Giancarlo Buitrago

Background: Colon cancer is the third most common malignancy in Colombia, only exceeded by prostate and breast cancers. It is the second most common cancer among females and the third most common among males. The epidemiology of this disease has changed in Colombia, and its peak incidence has now surpassed that of gastric cancer.

Aims: We aimed to determine the association between hospital surgical volume and mortality in patients with colon cancer undergoing surgical resection in Colombia.

Methods: This was a national retrospective cohort study based on administrative data and included adult patients undergoing surgical resection for colon cancer who were enrolled in Colombia's contributory health system between 2012 and 2017. We defined exposure as the hospital's surgical volume where the colon cancer surgery was performed. We classified the patients as exposed to a high surgical volume (above the 90th percentile of the provider distribution) and a low surgical volume (under the 90th percentile). The main outcomes were 30-day and 1-year mortality. Multivariate Poisson regressions were used to identify the association between exposure and mortality rates.

Results: The study included 4,647 patients, of which 4,188 underwent surgery at hospitals with a colectomy volume lower than 33 per year and 459 underwent surgery at institutions with volumes equal to or higher than 33 per year. In the multivariate analysis, after adjusting for observable variables, a lower risk of 30-day mortality was found in patients who underwent surgery at high surgical volume institutions (relative risk - RR 0.57, 95% confidence interval - 95%CI 0.033-0.97). No differences were found in the one-year mortality.

Conclusion: The high surgical volume of a hospital is associated with a 30-day mortality in colon cancer, as described in other studies, but the 1-year mortality did not show this association. Prospective studies are required to establish a causal relationship.

背景:结肠癌是哥伦比亚第三大最常见的恶性肿瘤,仅次于前列腺癌和乳腺癌。它是女性中第二常见的癌症,男性中第三常见的癌症。此病在哥伦比亚的流行病学发生了变化,其发病率高峰现已超过胃癌。目的:我们旨在确定哥伦比亚接受手术切除的结肠癌患者的医院手术量与死亡率之间的关系。方法:这是一项基于行政数据的全国性回顾性队列研究,纳入了2012年至2017年在哥伦比亚缴费卫生系统登记的接受结肠癌手术切除的成年患者。我们将暴露量定义为进行结肠癌手术的医院的手术量。我们将患者分为高手术量(高于提供者分布的第90个百分位数)和低手术量(低于第90个百分位数)。主要结局为30天死亡率和1年死亡率。使用多变量泊松回归来确定暴露与死亡率之间的关系。结果:本研究纳入4647例患者,其中4188例患者在结肠切除量小于33例/年的医院接受手术,459例患者在结肠切除量等于或大于33例/年的机构接受手术。在多因素分析中,调整可观察变量后,在大手术量机构接受手术的患者30天死亡风险较低(相对风险- RR 0.57, 95%置信区间- 95% ci 0.033-0.97)。在一年的死亡率上没有发现差异。结论:如其他研究所述,医院的高手术量与结肠癌患者30天死亡率相关,但1年死亡率并未显示出这种关联。需要前瞻性研究来建立因果关系。
{"title":"ASSOCIATION BETWEEN SURGICAL VOLUME AND MORTALITY FROM COLON CANCER IN COLOMBIA: A NATIONAL COHORT.","authors":"María Fernanda Castro-Cuarán, Edgar German Junca, Diego Felipe Gonzalez-Patiño, Giancarlo Buitrago","doi":"10.1590/0102-6720202400041e1835","DOIUrl":"10.1590/0102-6720202400041e1835","url":null,"abstract":"<p><strong>Background: </strong>Colon cancer is the third most common malignancy in Colombia, only exceeded by prostate and breast cancers. It is the second most common cancer among females and the third most common among males. The epidemiology of this disease has changed in Colombia, and its peak incidence has now surpassed that of gastric cancer.</p><p><strong>Aims: </strong>We aimed to determine the association between hospital surgical volume and mortality in patients with colon cancer undergoing surgical resection in Colombia.</p><p><strong>Methods: </strong>This was a national retrospective cohort study based on administrative data and included adult patients undergoing surgical resection for colon cancer who were enrolled in Colombia's contributory health system between 2012 and 2017. We defined exposure as the hospital's surgical volume where the colon cancer surgery was performed. We classified the patients as exposed to a high surgical volume (above the 90th percentile of the provider distribution) and a low surgical volume (under the 90th percentile). The main outcomes were 30-day and 1-year mortality. Multivariate Poisson regressions were used to identify the association between exposure and mortality rates.</p><p><strong>Results: </strong>The study included 4,647 patients, of which 4,188 underwent surgery at hospitals with a colectomy volume lower than 33 per year and 459 underwent surgery at institutions with volumes equal to or higher than 33 per year. In the multivariate analysis, after adjusting for observable variables, a lower risk of 30-day mortality was found in patients who underwent surgery at high surgical volume institutions (relative risk - RR 0.57, 95% confidence interval - 95%CI 0.033-0.97). No differences were found in the one-year mortality.</p><p><strong>Conclusion: </strong>The high surgical volume of a hospital is associated with a 30-day mortality in colon cancer, as described in other studies, but the 1-year mortality did not show this association. Prospective studies are required to establish a causal relationship.</p>","PeriodicalId":72298,"journal":{"name":"Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery","volume":"37 ","pages":"e1835"},"PeriodicalIF":0.0,"publicationDate":"2024-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11654462/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142781993","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TOTAL OXIDANT AND ANTIOXIDANT LEVELS IN PATIENTS WITH GALLBLADDER STONES OR RELATED COMPLICATIONS: ARE THEY IMPORTANT FOR TREATMENT? 胆囊结石或相关并发症患者的总氧化剂和抗氧化剂水平:它们对治疗重要吗?
Pub Date : 2024-12-02 eCollection Date: 2024-01-01 DOI: 10.1590/0102-6720202400043e1837
Muhammed Emin Çelik, Veysel Garani Soylu, Ayse Yilmaz

Background: Many free radicals result in an inflammatory process due to complications caused by gallstones. These free radicals are inactivated by various reactions and participate in different reactions. Molecules are oxidants and antioxidants that take an active role in almost every event that takes place in the body.

Aims: To analyse the changes in total antioxidant level (TAL) and total oxidant level (TOL) in the follow-up of patients hospitalized for cholelithiasis or its complications, showing the active oxidative stress, and to test the usability of these parameters in the evaluation of treatment success.

Methods: Forty-five patients took part in the study. Blood samples were taken twice, previous to surgery and 6 hours after surgery. Tissue samples were also obtained from patients who were operated. Then, the samples were sent to a laboratory to measure the total oxidant and antioxidant status of patients.

Results: The median for the TAL_before (pre-operation or hospitalization in non-operational) variable was 2.40 (interquartile range - IQR=0.50), and the median for the TAL_after variable was 2.20 (IQR=0.33). The median of the tissue-derived TAL variable was 0.32 (IQR=0.13), and the median of the TOL variable was 0.43 (IQR=0.52). The median value of the TAL_before variable for men was 2.50 (IQR=0.50), while the median value for the TAL_before variable for women was 2.30 (IQR=0.50). TAL_before variable values did not show a statistically significant difference according to gender (Z=1.446; p=0.154, p>0.05). Similarly, the median values of TOL_before variable by gender were similar (Z=0.614; p=0.545, p>0.05).

Conclusions: Cholelithiasis and its complications cause many inflammatory responses, ending with free radical formation. During follow-up, its level decreases due to consumption or success of the treatment.

背景:由于胆结石引起的并发症,许多自由基导致炎症过程。这些自由基被各种反应灭活,参与不同的反应。分子是氧化剂和抗氧化剂,在身体发生的几乎每一个事件中都起着积极的作用。目的:分析胆石症及其并发症住院患者随访中总抗氧化水平(TAL)和总氧化水平(TOL)的变化,显示胆石症患者的活性氧化应激,并检验这些参数在评价治疗成功中的可用性。方法:45例患者参与研究。术前和术后6小时采集两次血样。还从手术患者身上获得了组织样本。然后,将样品送到实验室测量患者的总氧化剂和抗氧化状态。结果:TAL_before(术前或非手术住院)变量的中位数为2.40(四分位数差- IQR=0.50), TAL_after变量的中位数为2.20(四分位数差- IQR=0.33)。组织源TAL变量的中位数为0.32 (IQR=0.13), TOL变量的中位数为0.43 (IQR=0.52)。男性TAL_before变量的中位数为2.50 (IQR=0.50),而女性TAL_before变量的中位数为2.30 (IQR=0.50)。TAL_before变量值在性别间差异无统计学意义(Z=1.446;p = 0.154, p > 0.05)。同样,不同性别的TOL_before变量的中位数相似(Z=0.614;p = 0.545, p > 0.05)。结论:胆石症及其并发症引起多种炎症反应,以自由基形成结束。在随访期间,其水平因消耗或治疗成功而下降。
{"title":"TOTAL OXIDANT AND ANTIOXIDANT LEVELS IN PATIENTS WITH GALLBLADDER STONES OR RELATED COMPLICATIONS: ARE THEY IMPORTANT FOR TREATMENT?","authors":"Muhammed Emin Çelik, Veysel Garani Soylu, Ayse Yilmaz","doi":"10.1590/0102-6720202400043e1837","DOIUrl":"10.1590/0102-6720202400043e1837","url":null,"abstract":"<p><strong>Background: </strong>Many free radicals result in an inflammatory process due to complications caused by gallstones. These free radicals are inactivated by various reactions and participate in different reactions. Molecules are oxidants and antioxidants that take an active role in almost every event that takes place in the body.</p><p><strong>Aims: </strong>To analyse the changes in total antioxidant level (TAL) and total oxidant level (TOL) in the follow-up of patients hospitalized for cholelithiasis or its complications, showing the active oxidative stress, and to test the usability of these parameters in the evaluation of treatment success.</p><p><strong>Methods: </strong>Forty-five patients took part in the study. Blood samples were taken twice, previous to surgery and 6 hours after surgery. Tissue samples were also obtained from patients who were operated. Then, the samples were sent to a laboratory to measure the total oxidant and antioxidant status of patients.</p><p><strong>Results: </strong>The median for the TAL_before (pre-operation or hospitalization in non-operational) variable was 2.40 (interquartile range - IQR=0.50), and the median for the TAL_after variable was 2.20 (IQR=0.33). The median of the tissue-derived TAL variable was 0.32 (IQR=0.13), and the median of the TOL variable was 0.43 (IQR=0.52). The median value of the TAL_before variable for men was 2.50 (IQR=0.50), while the median value for the TAL_before variable for women was 2.30 (IQR=0.50). TAL_before variable values did not show a statistically significant difference according to gender (Z=1.446; p=0.154, p>0.05). Similarly, the median values of TOL_before variable by gender were similar (Z=0.614; p=0.545, p>0.05).</p><p><strong>Conclusions: </strong>Cholelithiasis and its complications cause many inflammatory responses, ending with free radical formation. During follow-up, its level decreases due to consumption or success of the treatment.</p>","PeriodicalId":72298,"journal":{"name":"Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery","volume":"37 ","pages":"e1837"},"PeriodicalIF":0.0,"publicationDate":"2024-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11654457/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142782001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
THE GROWING EVIDENCE OF THE RELATIONSHIP BETWEEN OBESITY AND CANCER AND THE ROLE OF BARIATRIC SURGERY. 越来越多的证据表明肥胖和癌症之间的关系以及减肥手术的作用。
Pub Date : 2024-12-02 eCollection Date: 2024-01-01 DOI: 10.1590/0102-6720202400044e1838
Paulo Kassab, Álvaro Antônio Bandeira Ferraz, Anna Clara Hebling Mitidieri, Luiz Vicente Berti, Marco Aurélio Santo, Tiago Szego, Caio de Carvalho Zanon, Osvaldo Antônio Prado Castro, Wilson Rodrigues de Freitas Junior, Elias Jirjoss Ilias, Carlos Alberto Malheiros, Antônio Carlos Valez, Antônio Carlos Ligocki Campos

Obesity is recognized as a significant risk factor for various types of cancer. Although the incidence of some types of cancer across various primary sites is decreasing due to specific prevention measures (screening programs, smoking cessation), the incidence of neoplasms in the young population shows a significant increase associated with obesity. There is sufficient evidence to say that bariatric surgery has been shown to significantly lower the risk of developing obesity-associated cancers, which are linked to metabolic dysregulation, chronic low-grade systemic inflammation, and hormonal alterations such as elevated levels of insulin and sex hormones.

肥胖被认为是各种癌症的重要风险因素。尽管某些类型的癌症在不同原发部位的发病率由于特定的预防措施(筛查计划,戒烟)正在下降,但年轻人群中肿瘤的发病率显示出与肥胖相关的显著增加。有足够的证据表明,减肥手术已被证明可以显著降低患肥胖相关癌症的风险,而肥胖相关癌症与代谢失调、慢性低度全身性炎症以及胰岛素和性激素水平升高等激素改变有关。
{"title":"THE GROWING EVIDENCE OF THE RELATIONSHIP BETWEEN OBESITY AND CANCER AND THE ROLE OF BARIATRIC SURGERY.","authors":"Paulo Kassab, Álvaro Antônio Bandeira Ferraz, Anna Clara Hebling Mitidieri, Luiz Vicente Berti, Marco Aurélio Santo, Tiago Szego, Caio de Carvalho Zanon, Osvaldo Antônio Prado Castro, Wilson Rodrigues de Freitas Junior, Elias Jirjoss Ilias, Carlos Alberto Malheiros, Antônio Carlos Valez, Antônio Carlos Ligocki Campos","doi":"10.1590/0102-6720202400044e1838","DOIUrl":"10.1590/0102-6720202400044e1838","url":null,"abstract":"<p><p>Obesity is recognized as a significant risk factor for various types of cancer. Although the incidence of some types of cancer across various primary sites is decreasing due to specific prevention measures (screening programs, smoking cessation), the incidence of neoplasms in the young population shows a significant increase associated with obesity. There is sufficient evidence to say that bariatric surgery has been shown to significantly lower the risk of developing obesity-associated cancers, which are linked to metabolic dysregulation, chronic low-grade systemic inflammation, and hormonal alterations such as elevated levels of insulin and sex hormones.</p>","PeriodicalId":72298,"journal":{"name":"Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery","volume":"37 ","pages":"e1838"},"PeriodicalIF":0.0,"publicationDate":"2024-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11654459/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142782000","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1